Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Heng-wen Sun"'
Autor:
Ji-jin Wang, Han Shao, Li Zhang, Ming Jing, Wen-jing Xu, Heng-wen Sun, Zhi-wei Zhou, Yu-jing Zhang
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-12 (2023)
Abstract Background To explore the hematological toxicity (HT) induced by neoadjuvant chemoradiotherapy (nCRT) compared with neoadjuvant chemotherapy (nCT) and to identify the appropriate vertebral body (VB) dosimetric parameters for predicting HT in
Externí odkaz:
https://doaj.org/article/8b182f9a2a2f428ea0fc26cb30bc2c37
Autor:
Ji-jin Wang, Han Shao, Jin Yan, Ming Jing, Wen-jing Xu, Heng-wen Sun, Zhi-wei Zhou, Yu-jing Zhang
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 40, Iss , Pp 100617- (2023)
Background: Few studies concentrate on spleen dosimetry of radiotherapy for gastric cancer (GC). Although there is no consensus on the spleen dose-volume threshold for lymphopenia, several studies indicated that the higher the spleen dose, the higher
Externí odkaz:
https://doaj.org/article/10789a2a0f0b41e5a35ac0c143157b5b
Autor:
Ji-jin Wang, Han Shao, Li Zhang, Ming Jing, Wen-jing Xu, Heng-wen Sun, Zhi-wei Zhou, Yu-jing Zhang
Background To explore the hematological toxicity (HT) induced by neoadjuvant chemoradiotherapy (nCRT) compared with neoadjuvant chemotherapy (nCT) and to identify the appropriate vertebral body (VB) dosimetric parameters for predicting HT in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47fc6c503279d585981c4a2fa4172cc2
https://doi.org/10.21203/rs.3.rs-2202715/v1
https://doi.org/10.21203/rs.3.rs-2202715/v1
Publikováno v:
Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 30(4)
To determine the repair half-time (T1/2), a speed parameter of sub-lethal damage repair (SLDR), of human nasopharyngeal carcinoma (NPC) cell lines CNE1, HONE1, C666-1 and CNE2.A total radiation dose of 8 Gy divided into 4+4 Gy was delivered to the ce
Publikováno v:
Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 29(6)
To evaluate the outcomes of patients with unresectable massive primary liver cancer (PLC) receiving three-dimensional conformal radiotherapy (3-DCRT) combined with transcatheter arterial chemoembolization (TACE).From January 2001 to December 2004, 84